Study of the Safety and Efficacy of Fixed-dose Brexpiprazole (OPC-34712) as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder With and Without Anxious Distress

Clinical trial NCT02196506 · COMPLETED

Trial details

NCT number: NCT02196506
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Depressive Disorder Depression Depressive Disorder, Major Mood Disorders Mental Disorders

Start date: 2014-07-01
Primary completion: 2016-04-01
Enrollment: 837

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.